Back
Day Range
$8.03
$8.36
52-Week Range
$5.80
$16.44
Volume
3,745,404
50D / 200D Avg
$9.58
/
$11.13
Prev Close
$8.18
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -6.6 | 14.0 |
| P/B | 2.7 | 2.4 |
| ROE % | -54.9 | 11.4 |
| Net Margin % | -513.2 | 10.1 |
| Rev Growth 5Y % | 4.5 | 7.0 |
| D/E | 0.1 | 0.5 |
Key Takeaways
Revenue grew 4.46% annually over 5 years — modest growth
Debt/Equity of 0.12 — conservative balance sheet
Negative free cash flow of -216.89M
Revenue growth is decelerating — 1Y growth trails 5Y average by 23.13%
Growth
Revenue Growth (5Y)
4.46%
Revenue (1Y)-18.67%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-54.85%
ROIC-27.59%
Net Margin-513.17%
Op. Margin-521.04%
Safety
Debt / Equity
0.12
Current Ratio15.39
Interest Coverage-22.82
Valuation
P/E Ratio
-6.63
P/B Ratio2.69
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -18.67% | Revenue Growth (3Y) | -5.83% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 4.46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 51.82M | Net Income (TTM) | -265.94M |
| ROE | -54.85% | ROA | -32.91% |
| Gross Margin | 87.31% | Operating Margin | -521.04% |
| Net Margin | -513.17% | Free Cash Flow (TTM) | -216.89M |
| ROIC | -27.59% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.12 | Current Ratio | 15.39 |
| Interest Coverage | -22.82 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.63 | P/B Ratio | 2.69 |
| P/S Ratio | 34.03 | PEG Ratio | -0.52 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.76B | Enterprise Value | 1.11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 51.82M | 63.72M | 58.44M | 51.49M | 43.52M |
| Net Income | -265.94M | -193.51M | -80.74M | -71.04M | -6.55M |
| EPS (Diluted) | -1.42 | -1.22 | -1.02 | -0.97 | -0.98 |
| Gross Profit | 45.25M | 58.10M | 53.16M | 46.95M | 39.12M |
| Operating Income | -270.02M | -171.78M | -82.38M | -78.65M | -78.04M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 808.06M | 457.94M | 252.06M | 149.29M | 204.89M |
| Total Liabilities | 153.75M | 142.59M | 160.93M | 113.91M | 116.89M |
| Shareholders' Equity | 654.31M | 315.34M | 91.13M | 35.38M | 88.00M |
| Total Debt | 79.78M | 75.78M | 83.39M | 64.28M | 58.98M |
| Cash & Equivalents | 737.06M | 392.10M | 195.81M | 102.30M | 164.16M |
| Current Assets | 782.13M | 440.99M | 232.24M | 129.63M | 191.30M |
| Current Liabilities | 50.81M | 41.35M | 34.90M | 31.40M | 26.34M |